Literature DB >> 20586000

Quality-of-life measurements versus disease activity in systemic lupus erythematosus.

Adnan N Kiani1, Michelle Petri.   

Abstract

Systemic lupus erythematosus (SLE) is a chronic disease affecting the physical, social, and psychological well-being of patients. Different instruments have been developed to measure health-related quality of life, some of which are SLE-specific. Contributors to poor quality of life in patients with SLE include fatigue, fibromyalgia, depression, and cognitive dysfunction. Health-related quality of life is not strongly associated with disease activity or organ damage. The Medical Outcomes Survey Short Form 36 is the most common instrument used to measure quality of life in SLE.

Entities:  

Mesh:

Year:  2010        PMID: 20586000     DOI: 10.1007/s11926-010-0114-1

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  94 in total

1.  Validity and reliability of the EQ-5D self-report questionnaire in English-speaking Asian patients with rheumatic diseases in Singapore.

Authors:  N Luo; L H Chew; K Y Fong; D R Koh; S C Ng; K H Yoon; S Vasoo; S C Li; J Thumboo
Journal:  Qual Life Res       Date:  2003-02       Impact factor: 4.147

2.  Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables.

Authors:  J Juenger; D Schellberg; S Kraemer; A Haunstetter; C Zugck; W Herzog; M Haass
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

3.  A comparison of five health status instruments in patients with systemic lupus erythematosus (SLE).

Authors:  D D Gladman; M B Urowitz; A Ong; J Gough; A MacKinnon
Journal:  Lupus       Date:  1996-06       Impact factor: 2.911

4.  Functional disability and health-related quality of life in South Africans with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Romela Benitha; Mohammed Tikly
Journal:  Clin Rheumatol       Date:  2006-03-15       Impact factor: 2.980

5.  Measuring the quality of life of women with rheumatoid arthritis or systemic lupus erythematosus: a Swedish version of the Quality of Life Scale (QOLS).

Authors:  C S Burckhardt; B Archenholtz; A Bjelle
Journal:  Scand J Rheumatol       Date:  1992       Impact factor: 3.641

6.  Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course.

Authors:  Graciela S Alarcón; Gerald McGwin; América Uribe; Alan W Friedman; Jeffrey M Roseman; Barri J Fessler; Holly M Bastian; Bruce A Baethge; Luis M Vilá; John D Reveille
Journal:  Arthritis Rheum       Date:  2004-06-15

7.  Cognitive function in a systemic lupus erythematosus inception cohort.

Authors:  Michelle Petri; Mohammad Naqibuddin; Kathryn A Carson; Margaret Sampedro; Daniel J Wallace; Michael H Weisman; Stephen L Holliday; Patricia A Padilla; Robin L Brey
Journal:  J Rheumatol       Date:  2008-07-15       Impact factor: 4.666

8.  Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants.

Authors:  A Doria; S Rinaldi; M Ermani; F Salaffi; L Iaccarino; A Ghirardello; S Zampieri; S Della Libera; G Perini; S Todesco
Journal:  Rheumatology (Oxford)       Date:  2004-09-14       Impact factor: 7.580

9.  Fatigue in patients with systemic lupus erythematosus: the psychosocial aspects.

Authors:  Roald Omdal; Knut Waterloo; Wenche Koldingsnes; Gunnar Husby; Svein Ivar Mellgren
Journal:  J Rheumatol       Date:  2003-02       Impact factor: 4.666

10.  Quality of life over time in patients with systemic lupus erythematosus.

Authors:  Bindee Kuriya; Dafna D Gladman; Dominque Ibañez; Murray B Urowitz
Journal:  Arthritis Rheum       Date:  2008-02-15
View more
  22 in total

1.  Anti-NR2 antibodies, blood-brain barrier, and cognitive dysfunction.

Authors:  Gaurav Gulati; Philip H Iffland; Damir Janigro; Bin Zhang; Michael E Luggen
Journal:  Clin Rheumatol       Date:  2016-06-29       Impact factor: 2.980

Review 2.  Pathogenesis and treatment of atherosclerosis in lupus.

Authors:  Maureen McMahon; Brian Skaggs
Journal:  Rheum Dis Clin North Am       Date:  2014-06-10       Impact factor: 2.670

3.  Neuropsychiatric Symptoms in Lupus.

Authors:  Maria Gulinello; Jing Wen; Chaim Putterman
Journal:  Psychiatr Ann       Date:  2012-09

4.  Understanding systemic lupus erythematosus patients' desired outcomes and their perceptions of the risks and benefits of using corticosteroids.

Authors:  X Ng; S dosReis; R Beardsley; L Magder; C D Mullins; M Petri
Journal:  Lupus       Date:  2017-08-31       Impact factor: 2.911

Review 5.  Patient-reported outcomes in core domain sets for rheumatic diseases.

Authors:  Lilian H D van Tuyl; Maarten Boers
Journal:  Nat Rev Rheumatol       Date:  2015-09-01       Impact factor: 20.543

Review 6.  Central pain mechanisms in the rheumatic diseases: future directions.

Authors:  Kristine Phillips; Daniel J Clauw
Journal:  Arthritis Rheum       Date:  2013-02

7.  Chinese Herbal Medicine (Zi Shen Qing) for Mild-to-Moderate Systematic Lupus Erythematosus: A Pilot Prospective, Single-Blinded, Randomized Controlled Study.

Authors:  Linda L D Zhong; Zhao Xiang Bian; Jun Hua Gu; Xin Zhou; Yu Tian; Jian Chun Mao; Xiang Jun Chen
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-08       Impact factor: 2.629

8.  An update on belimumab for the treatment of lupus.

Authors:  Aikaterini Thanou-Stavraki; Amr H Sawalha
Journal:  Biologics       Date:  2011-02-14

9.  Relationships Between Adverse Childhood Experiences and Health Status in Systemic Lupus Erythematosus.

Authors:  Kimberly DeQuattro; Laura Trupin; Jing Li; Patricia P Katz; Louise B Murphy; Edward H Yelin; Stephanie Rush; Cristina Lanata; Lindsey A Criswell; Maria Dall'Era; Jinoos Yazdany
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-04       Impact factor: 5.178

10.  Quality of life among female patients with systemic lupus erythematosus in remission.

Authors:  Rudra Prosad Goswami; Rudrani Chatterjee; Parasar Ghosh; Geetabali Sircar; Alakendu Ghosh
Journal:  Rheumatol Int       Date:  2019-05-25       Impact factor: 3.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.